Anticholinergic drugs in subjects with Multiple Sclerosis (MS) and urinary symptoms.
Anticholinergic drugs versus either placebo or other medications for children over two years of age with asthma
Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults without neurological problems
Anticholinergic medication for excessive salivation caused by use of antipsychotics other than clozapine
Anticholinergic medication for neuroleptic-induced tardive dyskinesia
Anticholinergic therapy for acute asthma in children
Anticholinergics (various) for neuroleptic-induced parkinsonism
Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction
Anticholinergics for neuroleptic-induced acute akathisia
Anticholinergics for neuroleptic-induced parkinsonism and tardive dyskinesia
Anticholinergics for prolonged non specific cough in children
Anticholinergics versus placebo for neuroleptic-induced parkinsonism
Anticoagulant and antiplatelet drugs, or both, for reducing the risk of blood clots in susceptible individuals
Anticoagulant drugs and/or antiplatelet drugs for reducing the risk of blood clots and strokes in susceptible individuals
Anticoagulant treatment for subsegmental pulmonary embolism
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease
Anticoagulants compared with anti-inflammatory drugs or placebo for treating people who have venous blood clots
Anticoagulants for acute ischaemic stroke
Anticoagulants for intermittent claudication
Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack
Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack
Anticoagulants taken for longer periods to prevent deep vein thrombosis or pulmonary embolism after hip or knee replacement
Anticoagulants versus antiplatelet agents for acute ischaemic stroke
Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack
Anticoagulation for cerebral venous sinus thrombosis
Anticoagulation for people receiving long-term haemodialysis
Anticoagulation therapy for serious blood clots during pregnancy
Anticonvulsant drugs for acute and chronic pain
Anticonvulsant drugs for migraine prophylaxis
Anticonvulsant therapy for status epilepticus
Anticonvulsants for alcohol dependence
Anticonvulsants for alcohol withdrawal syndrome
Anticonvulsants for chronic low-back pain
Anticonvulsants for cocaine dependence
Anticonvulsants for fibromyalgia
Anticonvulsants for neonates with seizures
Anticonvulsants for restless legs syndrome
Anticonvulsants for tinnitus
Antidepressant drugs for narcolepsy
Antidepressant drugs for neuropathic pain - an overview of Cochrane reviews
Antidepressant drugs for treatment of depression in people living with HIV
Antidepressant medication for preventing postnatal depression
Antidepressants and anxiolytics for functional dyspepsia
Antidepressants and benzodiazepines for panic disorder in adults
Antidepressants and psychological treatments, alone or combined, for bulimia nervosa
Antidepressants compared with placebo for bulimia nervosa
Antidepressants compared with placebos for depressed older people
Antidepressants drugs compared with placebos for dysthymia
Antidepressants for agitation and psychosis in dementia
Antidepressants for anorexia nervosa
Antidepressants for chronic non-cancer pain in children and adolescents
Antidepressants for cocaine abuse and dependence
Antidepressants for depressed older people
Antidepressants for depression during pregnancy
Antidepressants for depression in medical illness
Antidepressants for depression in physically ill people
Antidepressants for generalized anxiety disorder (GAD)
Antidepressants for insomnia
Antidepressants for non-specific low-back pain
Antidepressants for osteoarthritis
Antidepressants for pain management in rheumatoid arthritis
Antidepressants for panic disorder in adults
Antidepressants for patients with tinnitus
Antidepressants for people with both schizophrenia and depression
Antidepressants for people with epilepsy and depression
Antidepressants for postnatal depression
Antidepressants for the negative symptoms of schizophrenia
Antidepressants for the treatment of children and adolescents with functional abdominal pain
Antidepressants for the treatment of depression in people with cancer
Antidepressants for the treatment of people with co-occurring depression and alcohol dependence
Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis
Antidepressants for treating neuropathic pain
Antidepressants plus benzodiazepines for major depression
Antidepressants versus placebo for depression in primary care
Antidepressants versus placebo for generalised anxiety disorder (GAD)
Antidepressants, benzodiazepines and azapirones for panic disorder in adults: a network meta-analysis
Antidotes for acute cardenolide (cardiac glycoside) poisoning
Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis
Antiepileptic drug monotherapy (single drug treatment) for epilepsy
Antiepileptic drugs for chronic non-cancer pain in children and adolescents
Antiepileptic drugs for preventing seizures in people with brain tumors
Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis (ICVT)
Antiepileptic drugs for the primary and secondary prevention of seizures after subarachnoid haemorrhage
Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis
Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy
Antiepileptic drugs for Tourette's syndrome
Antiepileptic drugs for treating recurrent aggression
Antiepileptic drugs for treating seizures in adults with brain tumours
Antiepileptic drugs to treat neuropathic pain or fibromyalgia- an overview of Cochrane reviews
Antiepileptic drugs versus no treatment or placebo for children with benign epilepsy with centro temporal spikes
Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for preventing migraine attacks in adults
Antifibrinolytic agent tranexamic acid for nasal haemorrhage (epistaxis)
Antifibrinolytic agents to reduce blood loss in the surgical correction of scoliosis (abnormal curvatures of the spine) in children
Antifibrinolytic amino acids for upper gastrointestinal bleeding in people with acute or chronic liver disease
Antifibrinolytic drugs to treat heavy bleeding after childbirth
Antifibrinolytic therapy to reduce haemoptysis
Antifibrinolytics (such as tranexamic acid) for treatment of heavy menstrual bleeding
Antifibrinolytics (tranexamic acid and epsilon-aminocaproic acid) to prevent bleeding in people with low platelets due to bone marrow failure
Antifungal agents for infants and children with invasive fungal infections
Antifungal agents for preventing fungal infections in critically ill adults and children with a normal number of neutrophils in the blood
Antifungal agents for the treatment of mucocutaneous candidiasis in neonates and children
Antifungal drugs (azoles) for allergic bronchopulmonary aspergillosis associated with asthma
Antifungal drugs used for prevention can significantly reduce the number of invasive fungal infections in liver transplant patients
Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV
Antifungal medicines for treating children with ringworm
Antifungal therapy for chronic rhinosinusitis
Antifungal treatments applied to the skin to treat seborrhoeic dermatitis
Antigen-specific active immunotherapy for ovarian cancer
Antiglucocorticoid and related treatments for psychosis
Antiglucocorticoid treatments for mood disorders
Antihelminthics in helminth endemic areas: effects on HIV infection
Antihistamines alone are not an effective treatment for the common cold, but might have a small effect in combination with decongestives
Antihistamines as an addition to topical nasal steroids for allergic rhinitis in children
Antihistamines for motion sickness
Antihistamines for motion sickness
Antihistamines for the common cold
Antihistamines versus aspirin for itching in late pregnancy
Antihistamines with or without decongestants for otitis media with effusion (OME) ('glue ear') in children
Antihypertensive agents for children with chronic kidney disease
Antihypertensive agents for dialysis patients
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus
Antihypertensive withdrawal for the prevention of cognitive decline
Antileukotriene agents compared with placebo in children and adults with mild asthma
Antimalarial drug combinations for treating uncomplicated malaria in pregnancy
Antimalarial drugs as a treatment of anaemia in children living in malaria-endemic areas.
Antimalarials for treating rheumatoid arthritis
Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction
Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients
Antimicrobial agents for preventing urinary tract infections in patients undergoing cystoscopy
Antimicrobial agents for treating acute uncomplicated urinary tract infection in women
Antimicrobial dressings attached to the central venous catheters in reducing catheter-related infections in newborn infants
Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization
Antimicrobial lock solutions for preventing infections in patients using a catheter for haemodialysis
Antimicrobial-impregnated central venous catheters to prevent bloodstream infection in newborn infants
Antimicrobials for chronic AIDS-associated diarrhoea in Adults
Antimotility drugs for managing acute diarrhoea in children
Antioxidant drugs for preventing lung cancer in healthy people
Antioxidant supplements cannot be recommended for gastrointestinal cancer prevention
Antioxidant supplements for liver disease
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
Antioxidant vitamin and mineral supplements to prevent the development of age-related macular degeneration (AMD)
Antioxidant vitamin and mineral supplements to slow down the progression of age-related macular degeneration (AMD)
Antioxidant vitamins and minerals for male subfertility
Antioxidant vitamins for preventing and slowing the progression of age-related cataract
Antioxidants as add-on treatment for people with schizophrenia
Antioxidants for acute pancreatitis
Antioxidants for idiopathic sudden sensorineural hearing loss
Antioxidants for preventing and reducing muscle soreness after exercise
Antioxidants for preventing pre-eclampsia
Antioxidants for treating amyotrophic lateral sclerosis
Antioxidants to reduce pain in chronic pancreatitis
Antiplatelet agents and anticoagulants for hypertension
Antiplatelet agents for preventing failure of peripheral arterial grafts
Antiplatelet agents for preventing pre-eclampsia and its complications
Antiplatelet agents for reducing risks in patients with peripheral arterial disease and cramping pain in legs on walking
Antiplatelet agents for the treatment of deep venous thrombosis
Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndrome
Antiplatelet drugs for preventing arterial and venous thrombotic events in patients with polycythaemia vera or essential thrombocythaemia
Antiplatelet therapy for aneurysmal subarachnoid haemorrhage
Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks
Antiplatelet therapy for preventing stroke in people with atrial fibrillation
Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm
Antiproteases for acute pancreatitis
Antipsychotic drugs for anorexia nervosa
Antipsychotic drugs for elderly people with late-onset schizophrenia
Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum
Antipsychotic medication for challenging behaviour in people with learning disability
Antipsychotic medication for childhood-onset schizophrenia
Antipsychotic medication for early episode schizophrenia
Antipsychotic medication for elderly people with schizophrenia
Antipsychotic medication versus placebo for people with both schizophrenia and learning disability
Antipsychotic medications for cocaine dependence
Antipsychotic-reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia
Antipsychotics for fibromyalgia symptoms in adults
Antipsychotics for people with epilepsy and psychosis
Antipsychotics for people with persistent negative symptoms of schizophrenia
Antipsychotics for the treatment of neuropathic pain in adults
Antipsychotics to treat delirium in hospitalised patients, not including those in intensive care units
Antipyretic measures for treating fever in malaria
Antiresorptive agents for the prevention of fractures after spinal cord injury
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure
Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals
Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy
Antiretroviral resistance testing in people living with HIV
Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection
Antiseptic prevents deaths in newborns
Antiseptic treatment (chlorhexidine) to prevent tooth decay in children and young people
Antiseptics for Burns
Antispasmodics for labour
Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants
Antistreptococcal interventions for guttate and chronic plaque psoriasis
Antithrombin for respiratory distress syndrome in preterm infants
Antithrombin III for critically ill patients
Antithrombotic drugs for carotid artery dissection
Antithrombotic drugs to prevent further blood vessel blockage after bypass surgery using vein grafts obtained from the same person (autologous) or artificial grafts in the legs
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction
Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia
Antithyroid drug regimen for treating Graves' hyperthyroidism
Antitumour antibiotic containing regimens for metastatic breast cancer
Antivenom for snake venom-induced neuromuscular paralysis
Antiviral agents for hepatitis B virus-related cirrhosis
Antiviral agents for treating CMV infection of the nervous system in people with HIV
Antiviral agents for treatment of herpes simplex virus infection in neonates
Antiviral drugs amantadine and rimantadine for preventing and treating the symptoms of influenza A in adults
Antiviral drugs can prevent cytomegalovirus (CMV) infection and disease after an organ transplant.
Antiviral drugs for sudden hearing loss (without known cause)
Antiviral drugs used as protective and preventive therapy reduce CMV disease and CMV-associated deaths in solid organ transplant recipients
Antiviral medication for the treatment of infectious mononucleosis (glandular fever)
Antiviral medicines, interferon, and corneal surface removal in the treatment of herpes simplex virus infection of the eye
Antiviral prophylaxis for varicella zoster in immunocompromised patients (excluding haematological malignancies)
Antiviral therapy for genital herpes for prevention of HIV transmission
Antiviral therapy for recurrent liver graft infection with hepatitis C virus
Antiviral therapy for symptomatic congenital cytomegalovirus infection in neonates and infants up to 3 months of age
Antiviral therapy to prevent the recurrence of chronic hepatitis C infection in patients undergoing liver transplantation
Antiviral treatment for Bell's palsy
Antiviral treatment for chronic hepatitis C in patients with HIV infection
Antiviral treatment for influenza infection in people with cystic fibrosis
Antiviral treatment for preventing nerve pain after shingles (postherpetic neuralgia)
Antiviral treatments for lamivudine-resistant chronic hepatitis B adult patients
Antivirals for recurrent respiratory papillomatosis
Antivirals may provide limited help for the common cold but they are not a cure and none are licensed
Apomorphine for the treatment of erectile dysfunction
Appetite stimulants for people with cystic fibrosis
Apply for the Cochrane-REWARD prize for reducing waste in research
Applying negative pressure rapidly or in steps for vacuum extraction assisted vaginal delivery
Applying positive pressure at the end of each breath during anaesthesia for prevention of mortality and postoperative pulmonary complications
Aptrotinin and tranexamic acid may show promise in decreasing blood loss and blood transfusion requirements
Aquatic exercise for people with osteoarthritis in the knee or hip
Aquatic exercise training for fibromyalgia
Aquatic therapy exercise for treating rheumatoid arthritis
Aqueous shunts for glaucoma
Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma
Arbidol for preventing and treating influenza in adults and children
Are angiotensin receptor blockers (ARBs) an effective treatment for heart failure?
Are anti-blood clotting drugs beneficial for people with chronic kidney disease?
Are antibiotics a safe and effective additional treatment for asthma exacerbations?
Are antibiotics more effective when given continuously or intermittently to people with bronchiectasis?
Are any effective treatment options available for the management of granulosa cell tumour of the ovary?
Are cardioselective beta-blockers a safe and effective treatment in patients with chronic obstructive pulmonary disease?
Are changes to diet effective to manage mineral and bone abnormalities in people with chronic kidney disease?
Are diuretics effective for treating people with nephrotic oedema?
Are EGFR inhibitors, alone or in combination with conventional chemotherapy, likely to improve outcome in women with ovarian cancer?
Are inhaled anticholinergics added to β2-agonists beneficial in children hospitalised with acute asthma?
Are inhalers containing umeclidinium bromide effective and safe for people with COPD?
Are interventions that are implemented in alcohol server settings (e.g. bars and pubs) effective for preventing injuries?
Are interventions to improve clinical incidence reporting effective?
Are non-absorbable disaccharides associated with beneficial or harmful effects in people with cirrhosis and hepatic encephalopathy?